Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 227.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,822 shares of the medical technology company's stock after buying an additional 19,327 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.06% of Teleflex worth $3,395,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its position in Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company's stock worth $26,000 after buying an additional 77 shares in the last quarter. Fifth Third Bancorp increased its position in Teleflex by 7.8% during the third quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company's stock worth $255,000 after buying an additional 151 shares in the last quarter. Osaic Holdings Inc. increased its position in Teleflex by 17.5% during the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company's stock worth $148,000 after buying an additional 186 shares in the last quarter. Hantz Financial Services Inc. increased its position in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company's stock worth $34,000 after buying an additional 199 shares in the last quarter. Finally, Empowered Funds LLC increased its position in Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company's stock worth $233,000 after buying an additional 230 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently commented on TFX shares. Royal Bank Of Canada reaffirmed a "sector perform" rating on shares of Teleflex in a research report on Tuesday, April 14th. Bank of America raised Teleflex from an "underperform" rating to a "neutral" rating and set a $135.00 price objective for the company in a research report on Monday, April 13th. Needham & Company LLC lifted their price objective on Teleflex from $138.00 to $147.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Teleflex in a research report on Friday, March 27th. Finally, Raymond James Financial raised Teleflex from a "market perform" rating to an "outperform" rating and set a $128.00 price objective for the company in a research report on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $138.50.
View Our Latest Research Report on TFX
Teleflex Price Performance
Shares of NYSE:TFX opened at $133.16 on Thursday. The company has a market cap of $5.89 billion, a P/E ratio of -6.48, a P/E/G ratio of 0.97 and a beta of 0.84. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The business has a fifty day simple moving average of $118.49 and a 200-day simple moving average of $116.73.
Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing analysts' consensus estimates of $3.73 by ($1.80). The firm had revenue of $569.00 million during the quarter, compared to analyst estimates of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. Teleflex's revenue was down 28.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts forecast that Teleflex Incorporated will post 6.77 EPS for the current year.
Teleflex Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, March 6th. Teleflex's payout ratio is currently -6.62%.
Teleflex Company Profile
(
Free Report)
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.